A detailed history of Walker Asset Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Walker Asset Management, LLC holds 7,943 shares of BMY stock, worth $458,787. This represents 0.28% of its overall portfolio holdings.

Number of Shares
7,943
Previous 7,828 1.47%
Holding current value
$458,787
Previous $325,000 26.46%
% of portfolio
0.28%
Previous 0.24%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$39.66 - $51.75 $4,560 - $5,951
115 Added 1.47%
7,943 $411,000
Q2 2024

Jul 12, 2024

BUY
$40.25 - $52.99 $55,182 - $72,649
1,371 Added 21.23%
7,828 $325,000
Q1 2024

Apr 10, 2024

BUY
$47.98 - $54.4 $21,591 - $24,480
450 Added 7.49%
6,457 $350,000
Q4 2023

Jan 08, 2024

BUY
$48.48 - $57.85 $96,960 - $115,700
2,000 Added 49.91%
6,007 $308,000
Q3 2023

Oct 27, 2023

BUY
$57.89 - $64.73 $752 - $841
13 Added 0.33%
4,007 $232,000
Q2 2023

Jul 13, 2023

BUY
$63.71 - $70.74 $1,847 - $2,051
29 Added 0.73%
3,994 $255,000
Q1 2023

Apr 11, 2023

BUY
$65.71 - $74.53 $2,431 - $2,757
37 Added 0.94%
3,965 $274,000
Q4 2022

Feb 01, 2023

SELL
$68.48 - $81.09 $9,244 - $10,947
-135 Reduced 3.32%
3,928 $282,000
Q3 2022

Oct 11, 2022

SELL
$0.13 - $76.84 $7 - $4,149
-54 Reduced 1.31%
4,063 $289,000
Q2 2022

Jul 29, 2022

SELL
$72.62 - $79.98 $18.6 Million - $20.4 Million
-255,661 Reduced 98.42%
4,117 $317,000
Q2 2022

Jul 25, 2022

BUY
$72.62 - $79.98 $18.6 Million - $20.4 Million
255,529 Added 6013.86%
259,778 $19.8 Million
Q1 2022

Apr 13, 2022

BUY
$61.48 - $73.72 $1,905 - $2,285
31 Added 0.73%
4,249 $310,000
Q4 2021

Apr 14, 2022

BUY
$53.63 - $62.52 $226,211 - $263,709
4,218 New
4,218 $263,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Walker Asset Management, LLC Portfolio

Follow Walker Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walker Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walker Asset Management, LLC with notifications on news.